Found 35 matching trials
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer PHASE2 This phase II trial compares the effect of giving cabozantinib with or with...
Show More Location
Mayo Clinic Hospital in Arizona
Learn More & Join Trial
Cemiplimab/Peg-Interferon-ฮฑ in Advanced CSCC PHASE1 The primary purpose of this research study is to test the safety and possib...
Show More Location
Miami Cancer Institute at Baptist Health, Inc.
Learn More & Join Trial
SAR439459 and Cemiplimab for the Treatment of Advanced or Unresectable Solid Tumors, Strategic Alliance, TACTIC TRIAL PHASE1 This is a phase Ib trial with SAR439459, a TGF-beta inhibitor, in combinati...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer PHASE2 This phase II trial tests how well photoimmunotherapy (PIT) with ASP-1929 i...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer PHASE2 This phase II trial tests the addition of chemotherapy, with carboplatin an...
Show More Location
Banner University Medical Center - Tucson
Learn More & Join Trial
Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer PHASE1 This phase I/II trial tests the safety and efficacy of split-course adaptiv...
Show More Location
Vanderbilt University/Ingram Cancer Center
Learn More & Join Trial
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy PHASE2 This pilot study is configured as a non-inferiority comparison of Performan...
Show More Location
Wake Forest Baptist Comprehensive Cancer Center
Learn More & Join Trial
Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma PHASE2 This phase II trial compares the effect of treatment with palbociclib alone...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer PHASE2 This phase II trial compares the effectiveness of cemiplimab with CDX-1140 ...
Show More Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Learn More & Join Trial
Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck PHASE2 This phase II trial studies the effect of cemiplimab in combination with lo...
Show More Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Learn More & Join Trial